Fig. 2: Treatment efficacy according to subgroups. | British Journal of Cancer

Fig. 2: Treatment efficacy according to subgroups.

From: Adding cetuximab to paclitaxel and carboplatin for first-line treatment of carcinoma of unknown primary (CUP): results of the Phase 2 AIO trial PACET-CUP

Fig. 2

The Forrest plots describe the Oddʼs ratio for patients with complete or partial remission (a) and the Hazard ratio for progression free survival (b) or overall survival (c) according to the baseline parameters (univariat analysis). * interaction between baseline parameter and treatment arm.

Back to article page